Together, these results provide a strong rationale to translate CD70-CAR-IL-15 NK cells to the clinic to improve outcomes for CRC and PDAC patients and potentially other tumor types that are characterized by a strong desmoplastic reaction. This evidence concerns the gene CD70 and neoplasm.